Atlas Trials

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Clinical trial NCT01137071 · TERMINATED

Trial details

NCT number
NCT01137071
Sponsor
Recepta Biopharma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Start date
2011-04-01
Primary completion
2015-06-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.